Harmony Biosciences Holdings HRMY
NASDAQ HRMY
$39.73 +0.16 (+0.40%)
As of: Oct 2, 2026 · 9:46 AM EDT

Harmony Biosciences Holdings (HRMY) Preferred Stock Liabilities (2019 - 2020)

Updated

Harmony Biosciences Holdings (HRMY) recorded Preferred Stock Liabilities of $434.01 million in Q2 2020.

Analysis

Harmony Biosciences Holdings (HRMY) Preferred Stock Liabilities (2019 - 2020) Analysis & Trends

At the end of FY2019, Harmony Biosciences Holdings reported Preferred Stock Liabilities of $411.28 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Harmony Biosciences Holdings 2.28 Bn -474.81 Mn 198.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 434.01 Mn
Dec 31, 2019 411.28 Mn
Sep 30, 2019 400.88 Mn
API Access

Harmony Biosciences Holdings Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=HRMY&period=max&api_key=YOUR_API_KEY